DENODO
23.6.2022 09:03:13 CEST | Business Wire | Press release
Denodo , the leader in data management, today announced that its customer LeasePlan, headquartered in the Netherlands and with business operations across the globe, has been chosen as the winner of the IDC’s 2022 European Data Strategy & Innovation Awards in the Data Management Excellence category. The winners were announced on June 9th, 2022 at the special awards ceremony as part of IDC’s 2022 European Data and Intelligence Summit in Sintra, Portugal.
IDC's European Data Strategy & Innovation Awards are focused on celebrating the European organizations that are blazing trails in this area and on improving awareness of "what works". According to Neil Ward-Dutton, VP AI, Automation and Analytics Europe, at IDC, "This is the third year of our European Data Strategy and Innovation Awards, and we were delighted to receive so many high-quality nominations from across the region."
IDC received 34 nominations for 3 award categories and LeasePlan edged past the other nominees in the Data Management excellence category to win the coveted title. According to IDC, "Nominations in this category were from enterprises that could demonstrate significant advances in their ability to manage data effectively and efficiently at scale. The overall winner was LeasePlan, for its creation of a logical data fabric across all its key data sources, which has helped the company in creating transformational new use cases in customer experience and convenience, such as predictive vehicle maintenance programs."
LeasePlan, one of the world’s leading Car-as-a-Service companies, has approximately 1.9 million vehicles under management in 29 countries. These vehicles generate a large amount of data that has to be integrated and contextualized to support the customer journey. What followed was LeasePlan’s next-gen data strategy, envisioned to encompass a logical data fabric across all its key data sources – modern, cloud-based and legacy – with a single point of access, to be supported by a Global Data Hub. According to Sumit Arya, the Head of Data and Solution Architecture at LeasePlan, “The Logical Data Fabric built on the Denodo Platform is a critical component of LeasePlan’s Global Data Hub to seamlessly build a foundation for data self-service and simplify transparent data migration. It has enabled us to create new business services and best support our drivers on every step of their journey.” Denodo Platform has also supported the data governance needs of the organization and facilitated its cloud modernization efforts with zero downtime for BI reporting while migrating legacy data marts to the Cloud in various business units across geographies.
“We want to congratulate our customer LeasePlan for its efforts and the innovative use of the Denodo Platform to support its data management needs and key business initiatives,” said Ravi Shankar, Senior Vice President and Chief Marketing Officer at Denodo. “The Denodo Platform provides an abstraction layer to create a single, secure point-of-entry to LeasePlan's entire data ecosystem. LeasePlan has also built a centralized framework for data governance by leveraging the metadata management and data catalog capabilities of the Denodo platform to ensure the highest level of self-service and data security. We are thrilled to see LeasePlan credited for the way they have applied our platform to make such an impact.”
Please Tweet : https://ctt.ac/hUnsp
About LeasePlan
LeasePlan, one of the world’s leading Car-as-a-Service companies, is transforming from an analogue to a fully digital business model. LeasePlan worked with Denodo and other technologies to create a logical data fabric across all its key data sources – modern, cloud-based and legacy – with a single point of access. This gives a foundation for data self-service and simplifies transparent data migration to the Cloud. Most notably, the data fabric approach has helped the company in creating transformational new use cases in customer experience and convenience, such as predictive vehicle maintenance programs.
About Denodo
Denodo is a leader in data management. The award-winning Denodo Platform is the leading data integration, management, and delivery platform using a logical approach to enable self-service BI, data science, hybrid/multi-cloud data integration, and enterprise data services. Realizing more than 400% ROI and millions of dollars in benefits, Denodo’s customers across large enterprises and mid-market companies in 30+ industries have received payback in less than 6 months. For more information, visit www.denodo.com or call +1 877 556 2531 (US) / +44 (0) 20 7869 8053 (UK) / +65 6950 7489 (Singapore).
View source version on businesswire.com: https://www.businesswire.com/news/home/20220623005168/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release
Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 08:03:00 CEST | Press release
Round led by SBI Group follows $51 million Series B raise in May 2026, marking ascent as one of the fastest-growing neobanking platforms. Capital will expand Own Network and deepen AI across stablecoin settlement, tokenization, and corridor banking. Fasset now processes more than $40 billion in annualized transaction volume, serving 3 million+ wallets and more than 1,000 enterprises across 125 countries. Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 07:11:00 CEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 01:01:00 CEST | Press release
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 21:11:00 CEST | Press release
Authorizations add selection of ZYN ULTRA products to PMI U.S.’s growing portfolio of better alternatives for legal-age adults who smoke or use traditional oral tobacco products Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to furth
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom